Business News›News›ET TV›Biocon subsidiary completes acquisition of Viatris' Global Biosimilars business for USD 3 billion
Biocon subsidiary completes acquisition of Viatris' Global Biosimilars business for USD 3 billion
Biocon Biologics, a subsidiary of listed biopharmaceutical company Biocon Ltd, on Tuesday announced that it has successfully completed its acquisition of the global biosimilars business of its partner Viatris for USD 3 billion.
01:52- 02:37
- 02:54
- 02:00
- 02:32
- 02:43
- 03:44
- 04:09
- 03:25
- 01:29
- 01:00
- 01:36
- 01:48
- 02:47
- 02:31
- 02:26
- 06:22
- 01:21
- 01:53
- 03:29
- 02:11
- 14:12
- 01:47
- 01:33
- 03:42
- 05:35
- 02:20
- 03:12
- 04:17
- 01:22
- 03:59
- 01:25
- 03:21
- 01:34
- 03:31
- 02:40
- 03:43
- 01:04
- 02:13
Related Videos
